Copyright
©The Author(s) 2016.
World J Gastroenterol. Apr 14, 2016; 22(14): 3829-3836
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3829
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3829
Parameter | n |
Age (yr) | |
median (range) | 51 (35-74) |
Gender | |
Male | 62 |
Female | 18 |
Differentiation | |
Poor | 34 |
Moderate | 41 |
Well | 5 |
Tumor number | |
Single | 64 |
Multiple | 16 |
Liver cirrhosis | |
Absent | 29 |
Present | 51 |
HBV infection | |
Absent | 15 |
Present | 65 |
Periportal embolus | |
Absent | 9 |
Present | 71 |
AFP (ng/mL) | |
< 400 | 52 |
≥ 400 | 28 |
TNM staging | |
I-II | 36 |
III-IV | 44 |
Five-year survival | |
Yes | 32 |
No | 48 |
- Citation: Pan LH, Yao M, Cai Y, Gu JJ, Yang XL, Wang L, Yao DF. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma. World J Gastroenterol 2016; 22(14): 3829-3836
- URL: https://www.wjgnet.com/1007-9327/full/v22/i14/3829.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i14.3829